Samsung Biologics, International Women's Day Event...Roche Korea Appoints New Lead in Anti-cancer Drugs and Specialties
Mar 06, 2025
|
▶Samsung Biologics will hold a commemorative event for the 'World Women's Day'
On March 8th 'World Women's Day', Samsung Biologics held various events for executives and employees. The event, which was held as part of efforts to build an organizational culture to realize gender equality, consisted of special lectures for executives and employees, diversity & inclusion quiz events, and an official pose photo campaign for Women's Day.On the 5th, Choi Jae-cheon, a professor at Ewha Womans University, was invited to prepare a special lecture for executives and employees. Professor Choi presented directions for the roles and actions of male and female executives and employees to realize a harmonious corporate culture under the theme of 「Realization of gender equality from a biological perspective」 at Samsung Biologics Global Hall. On the 4th and 5th, we had time to announce the system and benefits for realizing gender equality in the company through the 'Diversity & Inclusion Quiz' conducted by the in-house welfare center 'Bio Plaza'. The 'World Women's Day Official Pose Photo Campaign' was also held. During the week-long campaign, which began on the 24th of last month, executives and employees shared photos of official poses with one hand in the company. In addition, Samsung Biologics is operating various family-friendly systems to support the balance between work and life of executives and employees.
|
▶Korea Roche appoints Jinyoung Jung and Hyunmi Kim in the division of anticancer drugs and specialties
Korea Roche has appointed Jinyoung Jung's new lead (left of the picture) as the general manager of the Oncology and Hematology cluster and Kim Hyun-mi as the general manager of the Specialty Medicines cluster, respectively.Jinyoung Jung Reed graduated from Seoul National University's College of Pharmacy and has been in pharmaceutical marketing since 2009 through Mundiparma Korea and Pfizer Korea. Since joining Roche Korea in 2019, it has led the growth of the pipeline of liver and lung cancer treatments such as ALK-positive non-small cell lung cancer treatments, anti-PD-L1 immuno-cancer drugs, and VEGF-targeted treatments, and contributed to strengthening Roche's leadership in the domestic anticancer drug market. In addition, he has played a leading role in designing organizational operations and portfolio strategies as the general manager of the lung cancer division in Roche Asia-Pacific (APAC), and in maximizing synergies by strengthening cooperation between countries.
After graduating from Seoul National University's College of Pharmacy and earning a master's degree in the same graduate school, Kim Hyun-mi joined Janssen Korea in 2004 and took her first step into the pharmaceutical industry. Since then, he has led business growth in a wide range of fields such as blood cancer, solid cancer, immunology, and neuroscience, and has proven his business strategy planning and new business development capabilities in global markets such as Korea, the United States, China, and the Asia-Pacific (APAC). In particular, it laid the foundation for the supply of innovative drugs by establishing the first cell therapy launch strategy and developing market models in the Asia-Pacific (APAC) region, and until recently, it has actively led pipeline expansion and business growth as the general manager of Janssen Solid Cancer Division in China.
Hankook Roche plans to appoint two new leads with abundant experience and expertise in the pharmaceutical industry, strengthening its portfolio across various treatment areas, including solid and blood cancers, ophthalmic diseases, and neurological diseases, and consolidating Roche's leadership in innovative drugs.
|
▶Hailion Korea wins the "2025 Happiness Social Contribution Campaign" award for the Minister of Health and Welfare
'Haleon Korea' recently won the '2025 Happiness-plus-Social Contribution Campaign' award co-hosted by the Korean Journalists Association and the Korean Employers' Association. It was highly praised for its contribution to social contribution by donating oral health campaigns and products, healthcare services for the underprivileged, and tree planting activities for a clean environment. In the case of the dental care product brand PolyDent, it has joined hands with the Korean Dental Prosthetics Association to support the Dentist Day (July 1 of each year) campaign to improve awareness of dentures and guide management methods, and has donated about 68,000 PolyDent products to the National Food Bank and the Smile Foundation (a non-profit organization for oral health of the disabled). Sensodyne', a toothpaste brand exclusively for sensitive teeth, has been supporting the campaign by establishing Sensitive Teeth Day (November 2nd every year) with the Korean Dental Conservation Society. On the anniversary of its foundation every year, all executives and employees participate in healthcare volunteer activities to practice sharing to the local community on a regular basis. In addition, all employees are engaged in tree planting activities at Mapo Noeul Park, which was built on a landfill every year for Earth Day. This article was translated by Naver AI translator.
